Tirzepatide (Mounjaro) is a dual agonist, targeting both GLP-1 and GIP receptors, potentially offering enhanced weight loss benefits
If Semaglutide is exposed to freezing temperatures, it can lose its effectiveness due to the breakdown of its active ingredients
Your Coverage Depends On: Your BCBS affiliate - Which of the 33+ companies administers your plan Your plan type - Self-funded employers have more flexibility Your employer's decisions - They may opt in or out of drug coverage Timing - Foundayo just launched
1 Theres growing evidence that semaglutide may also protect kidney function
Benoist CC, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, Wayman GA, Harding JW
How can the PlexusDx Precision Peptide Genetic Test help my SSRI and weight loss plan